Allan Tong’s Discover Picks Chartwell jumped 13% on the Pfizer vaccine news and 3% on the Moderna. Since Nov. 9, the stock has been bubbling between $11-12. There's a little more room to run to its $12.32 price target. Rising Covid cases will challenge these LTC stocks, but more positive vaccine news will propel it further. Analyst and shareholder, Christine Poole, is reasonably correct in predicting CSH.UN will return to pre-Covid levels above $14 in 12 months or more. At least you're paid 5.14% to wait. Read 4 Reliable Covid Stocks and Recovery Stocks for our full analysis.

Allan Tong’s Discover Picks ITP stock 3.82% dividend yield based on a 51.75% payout ratio. Cash flow is strong. The PE has ticked up from 10.11x in late-March to the current 13.9x, but is far below the 20.68 of September 2019. It reported a winning report last week and hit fresh 52-week highs. Intertape offered guidance for Q4 of 10% growth, and six analysts give it a buy signal, including two upgrades after that report. The average price target is $23.50 which is nearly 10% higher than the current trading price. Read 4 Reliable Covid Stocks and Recovery Stocks for our full analysis.

Allan Tong’s Discover Picks The AZN stock currently trades at a 64x PE and pays a not-bad 2.69% dividend yield. It's trending $7 below its $59.73 price target, and has declined slightly to June levels. However, its PE has tumbled to levels last seen in December 2019. Three analysts rate it a strong buy, one a buy and another a hold, unchanged since August. Read 3 Promising Diversified Coronavirus Vaccine Stocks Ahead of the Game: Fall Update for our full analysis.

Allan Tong’s Discover Picks The divvy pays nearly 4%. Investors are already pushing up the Pfizer stock near 52-week highs and price target, both $41, though it trades at a PE of only 14.9x. Currently, one analyst rates Pfizer stock a strong buy, 11 more a buy, nine a hold, and one a sell, its strongest recommendations so far this year. It's a strong company, but upside may be limited. Read 3 Promising Diversified Coronavirus Vaccine Stocks Ahead of the Game: Fall Update for our full analysis.

Allan Tong’s Discover Picks Bulls points to a robust balance sheet and a dividend that has risen for 50 straight years. JNJ is more diversified than its peers, operating in consumer products, diagnostics (for surgeries which have been rebounding since the spring lockdown) as well as drugs. It also trades at a reasonable 22.5x PE and pays a 2.78% dividend. Read 3 Promising Diversified Coronavirus Vaccine Stocks Ahead of the Game: Fall Update for our full analysis.

Allan Tong’s Discover Picks Zebra’s PE is 36x, though that has climbed from 27x since the end of June. It’s currently trading at all-time highs, but there’s still growth ahead for this little-known name as e-commerce trends will endure beyond the pandemic. Among analysts, ZBRA stock boasts four strong buys, two buys and five holds, and has suffered only one analyst downgrade this year (from overweight to neutral). It’s beaten three of its last four quarters. Read 3 Forgotten Undervalued Stocks: ZBRA Stock, MFC Stock and BBBY Stock for our full analysis.

Allan Tong’s Discover Picks The MFC trailing PE remains a low 9.6x while the forward PE is 6x. The price-to-book has stayed at 0.75x during this pandemic. The dividend yield is nearly 6% and is safe, based on a 54% payout ratio. Quarterly revenue growth YOY is 24.2%, though quarterly earnings have sunk nearly 50%. Read 3 Forgotten Undervalued Stocks: ZBRA Stock, MFC Stock and BBBY Stock for our full analysis.

Allan Tong’s Discover Picks This month, BBBY stock reported its Q2 results and it blew away the street with an EPS of +50 cents vs. the estimated -23 cents. Its digital channels grew 89% as BBB’s online store and curb pick-up services added two million customers that quarter. As Covid continues into these colder months, online sales will surely continue, if not grow further. Read 3 Forgotten Undervalued Stocks: ZBRA Stock, MFC Stock and BBBY Stock for our full analysis.

Allan Tong’s Discover Picks NEE stock boasts a one-year return of 32% and almost 200% over five years. Revenue growth year-over-year stands at nearly 15%, double the sector (in the U.S). NextEra trades at a 34x PE and pays a 1.85% dividend. The stock has climbed 25% year-to-date and it currently sailing at all-time highs. In fact, it has popped 10% in the past two weeks, beyond $300, as the election campaign heats up. Read NEE Stock and BABA Stock: 3 Savvy Election-proof Stocks for our full analysis.

Allan Tong’s Discover Picks The Alibaba stock has run up twice as far, year-to-date, as Amazon, soaring 85% vs. 45%. A key reason is that China has tamed the Covid virus and America, frankly, has not. Alibaba stock trades at a 47.18x PE and boasts revenue growth YOY at 28.2%. By comparison, Amazon has a 122.67x PE and returned 20.45% YOY, also paying no divvy. Read NEE Stock and BABA Stock: 3 Savvy Election-proof Stocks for our full analysis.

Allan Tong’s Discover Picks IYH stock tracks the Dow Jones U.S. healthcare sector and counts (in this order) Johnson & Johnson (9.05% weight), UnitedHealth Group, Merck, Pfizer, AbbVie, Abbott Labs and Thermo Fisher as its top holdings. IYH stock charges a 0.43% MER and pays a 1.21% dividend yield. Like many of its holdings, IYH stock offers a low beta (0.78). Average volumes are a little light at 69,000, but not a worry. YTD, IYH has climbed nearly 10%. Read NEE Stock and BABA Stock: 3 Savvy Election-proof Stocks for our full analysis.

Allan Tong’s Discover Picks Analysts such as Jim Cramer would buy Pepsi stock now as the number of Covid cases could rise as the weather turns colder and more people stay at home to snack. Analysts expects its EPS to reach $1.50, which would return to last year’s levels. Pepsi pays a dividend just under 3%. The trailing PE has ballooned from 15.62x last December to the current 26.85x, which will give some investors pause. Read PEP and NVDA: 3 More Top Recognized ESG Investing Options for our full analysis.

Allan Tong’s Discover Picks In the climate change category. Depending on the evaluator and their methodology, Nvidia either scores very high (A- from the Carbon Disclosure Project in 2019) or mediocre (62.8% according to Newsweek, though that was in 2017). Nvidia could do better in its use of water, a key component in producing computer chips. Nvidia falters in human rights as questions arise about forced labour in parts of the world, based on two reports. One is by KnowTheChain, which awards Nvidia a failing grade of 30, compared to 70 by Hewlett Packard. Read PEP and NVDA: 3 More Top Recognized ESG Investing Options for our full analysis.

Allan Tong’s Discover Picks Power Corp whopping 6.67% dividend yield is considered safe at a 79% payout ratio. This stock appeals to income investors who don’t expect much stock appreciation. Power trades at a low 10x PE, which has actually fallen from 14.13x a year ago. So, this is a steady but boring dividend stock whose share price should slowly creep up in months to come. Are there better returns out there? Yes, but they’re also riskier. Read PEP and NVDA: 3 More Top Recognized ESG Investing Options for our full analysis.

Allan Tong’s Discover Picks The ride-sharing giant is the poster child of overhyped, underbought tech IPO's. It's traded above its $45 initial asking price of May 2019 only twice, which was brief and happened in its early days. The year began promisingly when it rose from $20 to $30. Then, Covid hit and the stock plunged to below $14. No surprise, but what was unexpected was the sharp snapback after the March 18 bottom to $37.10 on June 5 when the first wave of reopenings happened across North America. Of course, the number of car rides plunged, but sales of Uber Eats—the food delivery services—shot up 160% during the lockdown, in the U.K. for example. The food delivery business has kept Uber afloat. Read Uber Stock and Splunk Stock: 3 More Exciting Top Tech Stocks to Watch for our full analysis.